Sunday, August 28, 2005

Singapore carves niche in stem cell research

SINGAPORE (Reuters) - South Korea stole headlines after creating the world's first cloned dog, but the tiny city-state of Singapore is quietly preparing to take the fruits of its stem cell research straight to the market.

Steven Fang, chief executive of Singapore-based CyGenics AX> , said more Singapore-based firms are taking the greenfield research of U.S. and Korean scientists and turning it into marketable technology safe for human use.

[Source: Reuters, 28/08/2005]